Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB
暂无分享,去创建一个
[1] Xi Chen,et al. THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL , 2005, Drug Metabolism and Disposition.
[2] K. Geiger,et al. Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles , 2004, International journal of cancer.
[3] C F Dewey,et al. Apparatus for subjecting living cells to fluid shear stress. , 1982, The Review of scientific instruments.
[4] W. Pardridge,et al. Blood—Brain Barrier Genomics , 2001, Methods in molecular medicine.
[5] W. Hennink,et al. In Vivo Methods to Study Uptake of Nanoparticles into the Brain , 2010, Pharmaceutical Research.
[6] R. Yokel,et al. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses , 2010, Journal of drug targeting.
[7] N. Greig,et al. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain , 2004, Cancer Chemotherapy and Pharmacology.
[8] Bhavna,et al. Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor , 2007 .
[9] M. Nair,et al. Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier , 2010, International journal of nanomedicine.
[10] W. Pardridge. Blood-Brain Barrier Genomics , 2007, Stroke.
[11] R. Sharma,et al. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[12] D. A. Kharkevich,et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles , 1995 .
[13] L. Fenart,et al. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.
[14] Senshang Lin,et al. Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration. , 2005, Journal of pharmaceutical sciences.
[15] Ming Lei,et al. Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. , 2004, Advanced drug delivery reviews.
[16] Yan Zhang,et al. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] R. Löbenberg,et al. Influence of the surfactant concentration on the body distribution of nanoparticles. , 1999, Journal of drug targeting.
[18] A. Seelig. The use of monolayers for simple and quantitative analysis of lipid-drug interactions exemplified with dibucaine and substance P. , 1990, Cell biology international reports.
[19] M. Heimesaat,et al. SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood–brain barriers , 2011, Journal of drug targeting.
[20] D. A. Kharkevich,et al. Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.
[21] R. Cavalli,et al. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. , 2000, Pharmacological research.
[22] Xin-guo Jiang,et al. UEA I-bearing nanoparticles for brain delivery following intranasal administration. , 2007, International journal of pharmaceutics.
[23] J. Gee,et al. Astrocytes: regulation of brain homeostasis via apolipoprotein E. , 2005, The international journal of biochemistry & cell biology.
[24] S. Davis,et al. Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits , 1986 .
[25] R. Alyautdin,et al. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles , 1997 .
[26] B. Sabel,et al. Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier , 1998, Peptides.
[27] Rongqin Huang,et al. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo , 2010, Brain Research Bulletin.
[28] Nicholas A Peppas,et al. Molecular imprinting within hydrogels. , 2002, Advanced drug delivery reviews.
[29] Zhuang Liu,et al. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. , 2006, Angewandte Chemie.
[30] E. Souto,et al. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. , 2012, International journal of pharmaceutics.
[31] D. Gopinath,et al. 1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice , 2007, Journal of drug targeting.
[32] Y. Sugiyama,et al. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] L. Fenart,et al. A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.
[34] L. Ren,et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles , 2011, International journal of nanomedicine.
[35] K. Landfester,et al. The First Step into the Brain: Uptake of NIO‐PBCA Nanoparticles by Endothelial Cells in vitro and in vivo, and Direct Evidence for their Blood–Brain Barrier Permeation , 2008, ChemMedChem.
[36] H. Boriss. Brain Availability Is the Key Parameter for Optimising the Permeability of Central Nervous System Drugs , 2010 .
[37] B. Sabel,et al. Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice. , 2000, Life sciences.
[38] Alexander V Kabanov,et al. Nanogels for oligonucleotide delivery to the brain. , 2004, Bioconjugate chemistry.
[39] D. A. Kharkevich,et al. [Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles]. , 1996, Eksperimental'naia i klinicheskaia farmakologiia.
[40] A. Babbar,et al. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. , 2008, International journal of pharmaceutics.
[41] 郑俊海,et al. International Journal of Nanomedicine , 2022 .
[42] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.
[43] L. Illum. Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.
[44] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[45] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[46] Xun Sun,et al. Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[47] U. Bickel,et al. How to measure drug transport across the blood-brain barrier , 2011, NeuroRX.
[48] R. Müller,et al. Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate , 2002, Journal of drug targeting.
[49] S. Usami,et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Sharma,et al. Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats , 2009, Pharmaceutical Research.
[51] W. Surewicz,et al. Interaction of propranolol with model phospholipid membranes. Monolayer, spin label and fluorescent spectroscopy studies. , 1981, Biochimica et biophysica acta.
[52] S. Baboota,et al. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation. , 2012, Carbohydrate polymers.
[53] Meindert Danhof,et al. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood–brain barrier , 1997, Brain Research Reviews.
[54] J. Brillault,et al. Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models , 2002, Pharmaceutical Research.
[55] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[56] Tushar K. Vyas,et al. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. , 2008, International journal of pharmaceutics.
[57] Edward J. Rapp,et al. Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability study , 2006, Brain Research.
[58] G. Tosi,et al. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[59] X. Wu,et al. Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.
[60] T. Nagai,et al. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[61] T. Paunesku,et al. Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[62] P. Diwan,et al. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[63] C. Lohmann,et al. Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays , 2002, Journal of drug targeting.
[64] R. Müller,et al. The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis , 2009, Journal of drug targeting.
[65] C. Ropert,et al. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. , 1992, Biomaterials.
[66] K. Audus,et al. Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers , 1994 .
[67] Javed Ali,et al. Strategy for effective brain drug delivery. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[68] Murali Mohan Bommana,et al. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye , 2010, Nanotechnology.
[69] Sandip S Chavhan,et al. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[70] M. Michaelis,et al. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.
[71] J. Rao,et al. Fluorescence imaging in vivo: recent advances. , 2007, Current opinion in biotechnology.
[72] E. Neuwelt,et al. An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. , 2005, AJNR. American journal of neuroradiology.
[73] P. Gaillard,et al. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[74] R. Borchardt,et al. Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier. , 1995, Biochemical pharmacology.
[75] J. Kreuter,et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) , 1995, Brain Research.
[76] D. Begley,et al. Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells , 2000, The European journal of neuroscience.
[77] R. Gabathuler,et al. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.
[78] M. Nireekshan Kumar,et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[79] W. Pardridge,et al. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. , 1979, The Journal of clinical investigation.
[80] J. Nutt,et al. Strategies to advance translational research into brain barriers , 2008, The Lancet Neurology.
[81] B. Kapoor,et al. P-glycoprotein: pharmacological relevance , 2006 .
[82] T. Kundu,et al. Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: delivery of membrane-impermeable molecule to modulate gene expression in vivo. , 2008, Nano letters.
[83] D. Welty,et al. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate , 1993, Epilepsy Research.
[84] Wei Lu,et al. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. , 2006, Biomaterials.
[85] M A Vandelli,et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[86] Y. Kuo,et al. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. , 2007, International journal of pharmaceutics.
[87] Luca Cucullo,et al. In vitro blood-brain barrier models: current and perspective technologies. , 2012, Journal of pharmaceutical sciences.
[88] S. Rapoport,et al. Tight‐Junctional Modification as the Basis of Osmotic Opening of the Blood‐Brain Barrier a , 1986, Annals of the New York Academy of Sciences.
[89] Chen Jiang,et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.
[90] Jijin Gu,et al. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. , 2012, Biomaterials.
[91] P. Artursson,et al. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[92] J. Kreuter,et al. Use of nanoparticles for cerebral cancer. , 2008, Tumori.
[93] W. Cavenee,et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[94] J. Kreuter,et al. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .
[95] W H Oldendorf,et al. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. , 1970, Brain research.
[96] J. Kaufman,et al. Permeability of the blood‐brain barrier for atenolol studied by positron emission tomography , 1991, The Journal of pharmacy and pharmacology.
[97] A. Dalpiaz,et al. Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach , 2008, Molecules.
[98] Jie Pan,et al. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.
[99] M. Samanta,et al. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[100] S. Montoto,et al. Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. , 2008, Blood.
[101] Thomas Wisniewski,et al. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imaging , 2008, Journal of neuroscience research.
[102] J. Frangioni. In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.
[103] W. Pardridge,et al. Log(BB), PS products and in silico models of drug brain penetration. , 2004, Drug discovery today.
[104] M. Samanta,et al. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease , 2008, Brain Research.
[105] M. R. Kumar,et al. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[106] Xin-guo Jiang,et al. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles , 2009, Journal of drug targeting.
[107] Anders Tunek,et al. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. , 2007, Journal of medicinal chemistry.
[108] J. Kreuter,et al. Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.
[109] H. Gendelman,et al. Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1 , 2009, The Journal of Immunology.
[110] Rakesh K. Sharma,et al. Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels , 2006, Journal of drug targeting.
[111] Rongqin Huang,et al. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[112] H. Tsukada,et al. Evaluation of O-[(18)F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography. , 2009, Nuclear medicine and biology.
[113] W. Pardridge. Brain Drug Targeting: The Future of Brain Drug Development , 2001 .
[114] Xin-guo Jiang,et al. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats , 2006, Journal of drug targeting.
[115] P. Gao,et al. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[116] Lihong Liu,et al. Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.
[117] Jie Ren,et al. Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles , 2009, Journal of biomaterials science. Polymer edition.
[118] Bernhard A. Sabel,et al. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections , 1996, Brain Research.
[119] R. Nerem,et al. Effect of flow on the process of endothelial cell division. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[120] Xing Tang,et al. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[121] Iain Martin,et al. Prediction of blood-brain barrier penetration: are we missing the point? , 2004, Drug discovery today.
[122] J. Diamond,et al. Molecular forces governing non-electrolyte permeation through cell membranes , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[123] H. Galla,et al. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. , 2011, Biochemical and biophysical research communications.
[124] A. Misra,et al. Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting , 2008, Alzheimer disease and associated disorders.
[125] Wenwei Tang,et al. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[126] de Lange EC,et al. Microdialysis for pharmacokinetic analysis of drug transport to the brain. , 1999, Advanced drug delivery reviews.
[127] H. Berendsen,et al. Proton transport across transient single-file water pores in a lipid membrane studied by molecular dynamics simulations. , 1996, Biophysical journal.
[128] C. Soussain,et al. Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma , 2007, Clinical Cancer Research.
[129] D. Mishra,et al. Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake. , 2013, Chemical & pharmaceutical bulletin.
[130] J. Poirier,et al. 2 International Journal of Alzheimer ’ s Disease 2 . Structural Organization and Toxicological Properties of the APOE Protein 2 , 2011 .
[131] R. Mumper,et al. Paclitaxel nanoparticles for the potential treatment of brain tumors. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[132] S. Rapoport,et al. Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission Tomography , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[133] Tushar K. Vyas,et al. Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations. , 2008, Journal of pharmaceutical sciences.
[134] Mauro Ferrari,et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.
[135] D. Begley,et al. Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles , 2003, Pharmaceutical Research.
[136] P. Couvreur,et al. Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.
[137] N. Zhang,et al. Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. , 2008, International journal of pharmaceutics.
[138] A. Reichel. Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept , 2009, Chemistry & biodiversity.
[139] Sandip S Chavhan,et al. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route , 2011, Journal of drug targeting.
[140] S. Tzeng,et al. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury. , 2008, Biomaterials.
[141] Svetlana Gelperina,et al. Transport of drugs across the blood-brain barrier by nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[142] C F Dewey,et al. The dynamic response of vascular endothelial cells to fluid shear stress. , 1981, Journal of biomechanical engineering.
[143] T. Matsuda,et al. Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[144] A. Rawat,et al. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles , 2006, Journal of drug targeting.
[145] J. Varshosaz,et al. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model , 2011, International journal of nanomedicine.
[146] T. Maurer,et al. RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE , 2005, Drug Metabolism and Disposition.
[147] M. Bynoe,et al. Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier , 2011, The Journal of Neuroscience.
[148] E. Duysen,et al. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. , 2010, Chemico-biological interactions.
[149] A. Seelig,et al. A method to determine the ability of drugs to diffuse through the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[150] Lisbeth Illum,et al. Nanoparticles for direct nose-to-brain delivery of drugs. , 2009, International journal of pharmaceutics.
[151] Siling Wang,et al. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting. , 2010, International journal of pharmaceutics.
[152] Peter L. Bonate,et al. Animal models for studying transport across the blood-brain barrier , 1995, Journal of Neuroscience Methods.
[153] U. Sharma,et al. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. , 2012, Biomaterials.
[154] P. Couvreur,et al. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles , 1992, Investigational New Drugs.
[155] K. Kinzler,et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[156] K. Audus,et al. Characterization of an In Vitro Blood–Brain Barrier Model System for Studying Drug Transport and Metabolism , 1986, Pharmaceutical Research.
[157] Rishi Kapil,et al. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery , 2011, The Journal of pharmacy and pharmacology.
[158] Mehrdad Hamidi,et al. Brain drug targeting: a computational approach for overcoming blood-brain barrier. , 2009, Drug discovery today.
[159] Liang Jiang,et al. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model , 2009, Brain Research.
[160] G. Curran,et al. Development of a Smart Nano-vehicle to Target Cerebrovascular Amyloid Deposits and Brain Parenchymal Plaques Observed in Alzheimer’s Disease and Cerebral Amyloid Angiopathy , 2008, Pharmaceutical Research.
[161] P. Couvreur,et al. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles , 2008, Cancer Chemotherapy and Pharmacology.
[162] T. Aminabhavi,et al. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[163] B A Sabel,et al. Influence of Nanoparticles on the Brain‐to‐serum Distribution and the Metabolism of Valproic Acid in Mice , 2000, The Journal of pharmacy and pharmacology.
[164] J. Kreuter,et al. Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[165] Janine Doorduin,et al. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis. , 2010, Nuclear medicine and biology.
[166] W. Pardridge. Why is the global CNS pharmaceutical market so under-penetrated? , 2002, Drug discovery today.
[167] D. Luo,et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.
[168] M. Castanho,et al. In vitro blood-brain barrier models--latest advances and therapeutic applications in a chronological perspective. , 2010, Mini reviews in medicinal chemistry.
[169] I. Fichtner,et al. Influence of Surface-Modifying Surfactants on the Pharmacokinetic Behavior of 14C-Poly (Methylmethacrylate) Nanoparticles in Experimental Tumor Models , 2001, Pharmaceutical Research.
[170] A. Misra,et al. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain. , 2012, Journal of pharmaceutical sciences.
[171] P. Couvreur,et al. Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.
[172] Mansoor M. Amiji,et al. Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.
[173] Denis Guilloteau,et al. PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter , 2008, CNS neuroscience & therapeutics.
[174] E. Guatteo,et al. A dynamic model of the blood-brain barrier "in vitro". , 1996, Neurotoxicology.
[175] W. Pardridge,et al. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. , 1990, The Journal of pharmacology and experimental therapeutics.
[176] Jin-Oh You,et al. Feedback-regulated paclitaxel delivery based on poly(N,N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles. , 2008, Biomaterials.
[177] Han van de Waterbeemd,et al. Lipophilicity in PK design: methyl, ethyl, futile , 2001, J. Comput. Aided Mol. Des..
[178] Stina Syvänen,et al. On The Rate and Extent of Drug Delivery to the Brain , 2007, Pharmaceutical Research.
[179] W. Pardridge. BBB-Genomics: creating new openings for brain-drug targeting. , 2001, Drug discovery today.
[180] G. Tosi,et al. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[181] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[182] S. Charman,et al. Drug delivery: A key factor in realising the full therapeutic potential of drugs , 1999 .
[183] Patrick Couvreur,et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. , 2005, Bioconjugate chemistry.
[184] D. Mishra,et al. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity , 2012, Drug delivery.
[185] M. Ricci,et al. Solid lipid nanoparticles for targeted brain drug delivery. , 2007, Advanced drug delivery reviews.
[186] R. Löbenberg,et al. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[187] Thomas Wirth,et al. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[188] Jia-You Fang,et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. , 2012, International journal of pharmaceutics.
[189] A. Seelig,et al. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.
[190] P. Diwan,et al. β-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[191] T. Terasaki,et al. Blood-to-brain influx transport of nicotine at the rat blood–brain barrier: Involvement of a pyrilamine-sensitive organic cation transport process , 2013, Neurochemistry International.
[192] William Couet,et al. Indirect Evidence that Drug Brain Targeting Using Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles Is Related to Toxicity , 1999, Pharmaceutical Research.
[193] D. Begley,et al. Brain Targeting Of Nerve Growth Factor Using Poly(Butylcyanoacrylate) Nanoparticles , 2004 .
[194] Jim E Riviere,et al. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[195] K. Frei,et al. Molecular and cellular permeability control at the blood–brain barrier , 2001, Brain Research Reviews.
[196] P. Dore‐Duffy,et al. Role of the CNS microvascular pericyte in the blood‐brain barrier , 1998, Journal of neuroscience research.
[197] L. Rubin,et al. The cell biology of the blood-brain barrier. , 1999, Annual review of neuroscience.
[198] A. O. Kamel,et al. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. , 2012, Colloids and surfaces. B, Biointerfaces.
[199] Mansoor M Amiji,et al. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases , 2009, Expert opinion on drug delivery.
[200] R. Weissleder,et al. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. , 1995, The American journal of pathology.
[201] Sungho Jin,et al. Magnetic targeting of nanoparticles across the intact blood-brain barrier. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[202] Y. Cai,et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[203] S. Apparsundaram,et al. Unbound Brain Concentration Determines Receptor Occupancy: A Correlation of Drug Concentration and Brain Serotonin and Dopamine Reuptake Transporter Occupancy for Eighteen Compounds in Rats , 2009, Drug Metabolism and Disposition.
[204] Simon M. Lin,et al. Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases. , 2012, Drug discovery today.
[205] Lei Zhang,et al. Gum Arabic-Coated Magnetic Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor Imaging , 2009, The AAPS Journal.
[206] V. Narayanaswami,et al. Apolipoprotein E: from lipid transport to neurobiology. , 2011, Progress in lipid research.
[207] J. Kreuter,et al. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[208] D. A. Kharkevich,et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.
[209] S. Desrayaud,et al. The priorities/needs of the pharmaceutical industry in drug delivery to the brain , 2005 .
[210] K. Knight,et al. Intraarterial chemotherapy and osmotic blood‐brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system , 2008, Cancer.
[211] Harpreet S. Chadha,et al. Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. , 1995, Drug design and discovery.
[212] J. Leysen,et al. Partition coefficients of dopamine antagonists in brain membranes and liposomes. , 1989, Biochemical pharmacology.